Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-10-20
1993-03-02
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514304, A61K 3144
Patent
active
051909545
ABSTRACT:
The invention relates to the use of certain compounds which act as antagonists of 5-hydroxytryptamine (5-HT) at 5-HT.sub.3 receptors for the treatment of cognitive disorders such as attentional and memory deficits and dementia states.
REFERENCES:
patent: 4624961 (1986-11-01), Welstead, Jr.
patent: 4845115 (1989-07-01), Tyers
The Merck Manual (14th edition) 1982 pp. 1305, 1439 and 1462-1469.
Altman et al, Psychopharmacology, 1986, 90, 24-27.
Essman, Advances in Biochemical Psychopharmacology, 1974, 11, 265-274.
Glaxo Group Limited
Henley III Raymond J.
Waddell Frederick E.
LandOfFree
Methods for the treatment of cognitive disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the treatment of cognitive disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the treatment of cognitive disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-126783